A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.
Fixing gene defects with designer DNA is on the horizon after Google DeepMind launched a pioneering new AI tool.
Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.
Artificial intelligence has gotten a bad reputation lately, and often for good reason. But a team of scientists at Google’s ...
Google unveiled an artificial intelligence tool Wednesday that its scientists said would help unravel the mysteries of the ...
Scientists at Google DeepMind —the company’s artificial intelligence research arm—say they’ve created an A.I. tool that can ...
Model predicts effect of mutations on sequences up to 1 million base pairs in length and is adept at tackling complex ...
Non-coding DNA variants contribute to acute lymphoblastic leukemia (ALL) chemotherapy resistance. St. Jude Children's Research Hospital scientists have identified specific DNA variants in the ...
There are some genes that can promote cancer; they are sometimes called oncogenes, and in tumor cells, mutations are often found in these genes. When they are functioning normally, oncogenes are often ...
Researchers have revealed that so-called ‘junk DNA’ contains powerful switches that help control brain cells linked to Alzheimer’s disease. When people picture DNA, they often imagine a set of genes ...
Morning Overview on MSN
New AI model could radically change genetic testing and drug discovery
A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results